目的 觀察腦血康膠囊聯合腦苷肌肽注射液治療高血壓腦出血的臨床療效。方法 選取2015年7月-2016年6月在澄邁縣人民醫(yī)院就診的高血壓腦出血患者86例，隨機分為對照組和治療組，每組各43例。對照組于術后第1天靜脈滴注腦苷肌肽注射液，10 mL稀釋于生理鹽水250 mL中，1次/d。治療組在對照組的基礎上口服腦血康膠囊，1粒/次，3次/d。兩組患者均治療28 d。評價兩組臨床療效，同時比較兩組患者治療前后神經功能缺損評分（NIHSS）和生活質量評分（ADL）評分。結果 治療后，對照組和治療組的總有效率分別為72.09%、90.70%，兩組比較差異有統(tǒng)計學意義（P<0.05）。治療后，兩組患者NIHSS評分顯著降低，ADL評分顯著升高，同組治療前后比較差異具有統(tǒng)計學意義（P<0.05）；且治療組患者NIHSS和ADL評分顯著優(yōu)于對照組患者，兩組比較差異具有統(tǒng)計學意義（P<0.05）。結論 腦血康膠囊聯合腦苷肌肽注射液治療高血壓腦出血臨床療效確切，神經功能及生活能力改善明顯，具有一定的臨床推廣應用價值。

Objective To observe the clinical effect of Naoxuekang Capsules combined with Cattle Encephalon Glycoside and Ignotin Injection in treatment of hypertensive cerebral hemorrhage. Methods Patients (86 cases) with hypertensive cerebral hemorrhage in Chengmai County People's Hospital from July 2015 to June 2016 were randomly divided into control and treatment groups, and each group had 43 cases. Patients in the control group were iv administered with Cattle Encephalon Glycoside and Ignotin Injection, 10 mL diluted into normal saline 250 mL, once daily. Patients in the treatment group were po administered with Naoxuekang Capsules on the basis of the control group, 1 grain/time, three times daily. Patients in two groups were treated for 28 d. After treatment, the clinical efficacy was evaluated, and the NIHSS and ADL scores in two groups before and after treatment were compared. Results After treatment, the clinical efficacies in the control and treatment groups were 72.09% and 90.70%, respectively, and there was difference between two groups (P < 0.05). After treatment, the NIHSS scores in two groups were significantly decreased, but the ADL score was significantly increased, and the difference was statistically significant in the same group (P < 0.05). The NIHSS and ADL scores in the treatment group were significantly better than those in the control group, with significant difference between two groups (P < 0.05). Conclusion Naoxuekang Capsules combined with Cattle Encephalon Glycoside and Ignotin Injection have definite clinical efficacy in treatment of hypertensive cerebral hemorrhage, and can significantly improve neurological function and life ability, which has a certain clinical application value.